Feb. 14 (Bloomberg) -- Czech tennis player Barbora Zahlavova Strycova was suspended for six months for failing a drug test in October during a tournament in Paris.
The 26-year-old, who is ranked 124th in the world by the WTA tour, was found to have used sibutramine, a stimulant, the International Tennis Federation said today in an e-mailed statement. Strycova, a member of the Czech Fed Cup team, said she didn’t realize the drug was in a supplement, ACAI Berry Thin, that she was taking.
Her suspension was backdated to Oct. 16, 2012 and will end April 15, the ITF said. She also was disqualified from two tournaments, forfeiting ranking points and prize money.
To contact the editor responsible for this story: Christopher Elser at email@example.com